Greetings! On behalf of our team, I'm delighted to share a few updates related to where we've been and what is happening in diabetes research. Thank you for reading, and as always, your feedback and input are welcomed!
Recently, a core group of our team attended the 84th Annual American Diabetes Association Scientific Sessions where we witnessed firsthand the remarkable advancements in our field. The energy and innovation present re-invigorated and inspired us as we returned home and prepare for a busy summer season of research and community engagement.
SDRI is at the forefront of translating cutting-edge research findings into practical, real-world applications. Our dedicated team is working tirelessly to bring the latest innovations from the laboratory to the clinic, ensuring that our patients benefit from the most advanced care available.
The future of diabetes care is bright, and SDRI is committed to leading the charge. In the coming months, we will be launching new research initiatives and clinical trials that promise to push the boundaries of what's possible in diabetes treatment.
I invite you to stay connected with us through our website and social media channels to keep up with our latest developments. Your continued support and engagement are crucial as we work towards our shared vision of reducing the burden of diabetes.
Yours in purpose and progress,
|
Elizabeth Thompson
Chief Executive Officer
|
|
|
Greetings! On behalf of our team, I'm delighted to share a few updates related to where we've been and what is happening in diabetes research. Thank you for reading, and as always, your feedback and input are welcomed!
Recently, a core group of our team attended the 84th Annual American Diabetes Association Scientific Sessions where we witnessed firsthand the remarkable advancements in our field. The energy and innovation present re-invigorated and inspired us as we returned home and prepare for a busy summer season of research and community engagement.
SDRI is at the forefront of translating cutting-edge research findings into practical, real-world applications. Our dedicated team is working tirelessly to bring the latest innovations from the laboratory to the clinic, ensuring that our patients benefit from the most advanced care available.
The future of diabetes care is bright, and SDRI is committed to leading the charge. In the coming months, we will be launching new research initiatives and clinical trials that promise to push the boundaries of what's possible in diabetes treatment.
I invite you to stay connected with us through our website and social media channels to keep up with our latest developments. Your continued support and engagement are crucial as we work towards our shared vision of reducing the burden of diabetes.
Yours in purpose and progress,
|
Elizabeth Thompson
Chief Executive Officer
|
|
|
|
The ADA’s Scientific Sessions, attended by thousands annually, is the premier diabetes conference for the latest advancements in diabetes research, prevention, and care. SDRI's team presented five posters showcasing innovative findings and demonstrating SDRI's leading position in diabetes research.
|
SDRI's team proudly representing at this year's ADA Scientific Sessions, highlighting groundbreaking advancements in diabetes research and patient care.
|
SDRI's team met with Dr. Anne Peters, professor of clinical medicine at the USC Keck School of Medicine, and a leading endocrinologist in Beverly Hills and in underserved East Los Angeles.
|
SDRI's team with Dr. Trang Ly, Sr. VP & Medical Director at Insulet, and Leslie Barrett, MS, RD, CDCES, Director, Medical Affairs at Insulet. As a trusted site for Insulet's clinical research trials, we are excited to share the ground-breaking results from the Omnipod 5 AID System pivotal trial for type 2 diabetes. Read the results here. SECURE-T2D was also highlighted as a breakthrough study of AID in type 2 diabetes by ADA’s official press program.
|
SDRI's Kristin Castorino, DO, BC-ADM, VP, Clinical Research and Senior Investigator and Kara Hornbuckle, VP, Development & Public Affairs, met up with Francine Kaufman, MD. Dr. Kaufman was honored with the 2024 Lois Jovanovic Transformative Woman in Diabetes Award, presented by the Women's Interprofessional Network of the American Diabetes Association. This award celebrates women who have made significant contributions to the field of diabetes and positively impacted the lives of those living with the condition.
|
Andrew Koutnik, Research Scientist at SDRI, presented key research findings at ADA of the longest known longitudinal report of a ketogenic diet in a patient at high risk for cardiovascular disease (type 1 diabetes).
|
SDRI's team enjoyed meeting with key leaders from Mannkind Corporation. Our partnerships with industry leaders are crucial in our mission to improve the lives of those affected by diabetes. By joining forces with industry pioneers, we're accelerating the pace of research.
|
SDRI's team met up with Dr. Jordan Pinsker, Chief Medical Officer at Tandem Diabetes Care, and Noah Gray, Kansas City Chiefs tight end, who lives with type 1 diabetes.
|
Ashley Thorsell, MD, presented SDRI's research findings from the clinical research trial, Acceptability and Impact of a Spanish-Language Diabetes Management Smartphone Application (mySugr PRO) in Hispanic/Latino Adults with Uncontrolled Type 2 Diabetes. The results of this trial showed that the mySugr PRO app helped not only improve diabetes self-efficacy and distress, but also motivation and intention to improve blood glucose control.
|
|
|
The ADA’s Scientific Sessions, attended by thousands annually, is the premier diabetes conference for the latest advancements in diabetes research, prevention, and care. SDRI's team presented five posters showcasing innovative findings and demonstrating SDRI's leading position in diabetes research.
|
SDRI's team proudly representing at this year's ADA Scientific Sessions, highlighting groundbreaking advancements in diabetes research and patient care.
|
SDRI's team met with Dr. Anne Peters, professor of clinical medicine at the USC Keck School of Medicine, and a leading endocrinologist in Beverly Hills and in underserved East Los Angeles.
|
SDRI's team with Dr. Trang Ly, Sr. VP & Medical Director at Insulet, and Leslie Barrett, MS, RD, CDCES, Director, Medical Affairs at Insulet. As a trusted site for Insulet's clinical research trials, we are excited to share the ground-breaking results from the Omnipod 5 AID System pivotal trial for type 2 diabetes. Read the results here. SECURE-T2D was also highlighted as a breakthrough study of AID in type 2 diabetes by ADA’s official press program.
|
SDRI's Kristin Castorino, DO, BC-ADM, VP, Clinical Research and Senior Investigator and Kara Hornbuckle, VP, Development & Public Affairs, met up with Francine Kaufman, MD. Dr. Kaufman was honored with the 2024 Lois Jovanovic Transformative Woman in Diabetes Award, presented by the Women's Interprofessional Network of the American Diabetes Association. This award celebrates women who have made significant contributions to the field of diabetes and positively impacted the lives of those living with the condition.
|
Andrew Koutnik, Research Scientist at SDRI, presented key research findings at ADA of the longest known longitudinal report of a ketogenic diet in a patient at high risk for cardiovascular disease (type 1 diabetes).
|
SDRI's team enjoyed meeting with key leaders from Mannkind Corporation. Our partnerships with industry leaders are crucial in our mission to improve the lives of those affected by diabetes. By joining forces with industry pioneers, we're accelerating the pace of research.
|
SDRI's team met up with Dr. Jordan Pinsker, Chief Medical Officer at Tandem Diabetes Care, and Noah Gray, Kansas City Chiefs tight end, who lives with type 1 diabetes.
|
Ashley Thorsell, MD, presented SDRI's research findings from the clinical research trial, Acceptability and Impact of a Spanish-Language Diabetes Management Smartphone Application (mySugr PRO) in Hispanic/Latino Adults with Uncontrolled Type 2 Diabetes. The results of this trial showed that the mySugr PRO app helped not only improve diabetes self-efficacy and distress, but also motivation and intention to improve blood glucose control.
|
|
|
|
You are invited to join us for SDRI's 16th Annual Taste of the Vine fundraiser. Twenty top-tier Santa Barbara County purveyors will pour sought-after wines, spirits, beer, and non-alcoholic cocktails.
Indulge in an array of appetizers, followed by a sit-down dinner prepared by duo catering.
Sponsorship opportunities available! Email Teri Creath, tcreath@sansum.org for more information, or click below.
|
|
|
You are invited to join us for SDRI's 16th Annual Taste of the Vine fundraiser. Twenty top-tier Santa Barbara County purveyors will pour sought-after wines, spirits, beer, and non-alcoholic cocktails.
Indulge in an array of appetizers, followed by a sit-down dinner prepared by duo catering.
Sponsorship opportunities available! Email Teri Creath, tcreath@sansum.org for more information, or click below.
|
|
|
|
Join our pediatric clinical research trials today!
|
Are you or someone you know living with type 1 diabetes? If so, we have an incredible opportunity for you to participate in cutting-edge clinical research at SDRI. Participants must be able to attend clinic visits at SDRI in Santa Barbara, CA.
|
|
|
Join our pediatric clinical research trials today!
|
Are you or someone you know living with type 1 diabetes? If so, we have an incredible opportunity for you to participate in cutting-edge clinical research at SDRI. Participants must be able to attend clinic visits at SDRI in Santa Barbara, CA.
|
|
|
|
Strategic Promotions Drive Innovation and Patient Care
|
SDRI is pleased to announce the promotion of four esteemed employees to pivotal leadership roles. These promotions are a testament to their expertise, dedication, and significant contributions to SDRI’s mission of advancing diabetes research and improving patient care.
|
|
|
Strategic Promotions Drive Innovation and Patient Care
|
SDRI is pleased to announce the promotion of four esteemed employees to pivotal leadership roles. These promotions are a testament to their expertise, dedication, and significant contributions to SDRI’s mission of advancing diabetes research and improving patient care.
|
|
|
|
SDRI Welcomes Esteemed Leaders to the Board of Trustees
|
(SDRI) is proud to welcome two distinguished individuals, Yvette Giller and Daren Dickerson, to the Board of Trustees. Both individuals share SDRI’s unwavering dedication to advancing diabetes research and improving the lives of those impacted by diabetes.
|
|
|
SDRI Welcomes Esteemed Leaders to the Board of Trustees
|
(SDRI) is proud to welcome two distinguished individuals, Yvette Giller and Daren Dickerson, to the Board of Trustees. Both individuals share SDRI’s unwavering dedication to advancing diabetes research and improving the lives of those impacted by diabetes.
|
|
|
Dedicated to improving the lives of people impacted by diabetes through research, education, and clinical care.
|
| |
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
2219 Bath Street | Santa Barbara, None 93105 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
| |
|
|
